https://talphera.com/resource/pharmacokinetic-properties-of-a-sufentanil-sublingual-tablet-intended-to-treat-acute-pain/ 2023-12-19T16:49:32+00:00 https://talphera.com/resource/the-newest-battlefield-opioid-sublingual-sufentanil-a-proposal-to-refine-opioid-usage-in-the-u-s-military/ 2023-12-19T16:51:20+00:00 https://talphera.com/resource/the-role-of-nafamostat-mesylate-in-continuous-renal-replacement-therapy-among-patients-at-high-risk-of-bleeding/ 2023-12-19T16:51:27+00:00 https://talphera.com/resource/nafamostat-mesilate-as-an-anticoagulant-during-continuous-renal-replacement-therapy-in-patients-with-high-bleeding-risk/ 2023-12-19T16:52:12+00:00 https://talphera.com/resource/nafamostat-mesilate-for-anticoagulation-in-continuous-renal-replacement-therapy/ 2023-12-19T16:54:04+00:00 https://talphera.com/resource/nafamostat-mesylate-improved-survival-outcomes-of-sepsis-patients-who-underwent-blood-purification-a-nationwide-registry-study-in-japan/ 2023-12-19T17:03:12+00:00 https://talphera.com/resource/low-dose-nafamostat-mesilate-in-hemodialysis-patients-at-high-bleeding-risk/ 2023-12-19T20:18:25+00:00 https://talphera.com/resource/the-use-of-nafamostat-mesilate-as-an-anticoagulant-during-continuous-renal-replacement-therapy-for-children-with-a-high-risk-of-bleeding/ 2023-12-19T20:19:47+00:00 https://talphera.com/resource/ability-of-nafamostat-mesilate-to-prolong-filter-patencyduring-continuous-renal-replacement-therapy-inpatients-at-high-risk-of-bleeding-a-randomizedcontrolled-study/ 2023-12-19T20:20:26+00:00 https://talphera.com/resource/efficacy-and-safety-of-nafamostat-mesilate-anticoagulation-in-blood-purification-treatment-of-critically-ill-patients-a-systematic-review-and-meta-analysis/ 2023-12-19T20:21:04+00:00 https://talphera.com/resource/comparison-of-nafamostat-mesilate-and-unfractionated-heparin-as-anticoagulants-during-continuous-renal-replacement-therapy/ 2023-12-19T20:22:37+00:00 https://talphera.com/resource/saline-versus-nafamostat-mesilate-anticoagulation-forcontinuous-veno-venous-hemofiltration-cvvh-inpatients-at-high-risk-of-bleeding-a-prospective-study/ 2023-12-19T20:24:40+00:00 https://talphera.com/resource/continuous-renal-replacement-therapy-a-worldwide-practice-survey-the-beginning-and-ending-supportive-therapy-for-the-kidney-b-e-s-t-kidney-investigators/ 2023-12-19T20:25:20+00:00 https://talphera.com/resource/anticoagulation-practices-for-continuous-renal-replacement-therapy-a-survey-of-physicians-from-the-united-states/ 2024-01-29T14:22:27+00:00 https://talphera.com/resource/comparison-of-nafamostat-mesilate-to-citrate-anticoagulation-in-pediatric-continuous-kidney-replacement-therapy/ 2024-01-29T14:23:12+00:00